![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessPrognosis significance and potential association between ALDOA and AKT expression in colorectal cancer
Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive tract and a leading cause of cancer-related death worldwide. Since many CRC patients are diagnosed already in the advanced st...
-
Article
Open AccessRetroperitoneal totally endoscopic prosthetic repair of lumbar hernia
Lumbar hernia is a rare lateral abdominal wall hernia. Various surgical repair strategies have been recorded, but there is currently no unified standard. A Chinese surgeon recently revealed a novel technique f...
-
Article
Open AccessPrognosis value and positive association of Rab1A/IL4Rα aberrant expression in gastric cancer
Gastric cancer (GC) is the most common gastrointestinal cancer and the leading cause of worldwide cancer-associated mortality. Several GC patients are diagnosed at the advanced stage with an unsatisfactory 5-y...
-
Article
Open AccessAbsent in melanoma 2 suppresses gastric cancer cell proliferation and migration via inactivation of AKT signaling pathway
Gastric cancer (GC) is the third leading cause of cancer-related mortality worldwide, and poses a great threat to public health. Absent in melanoma 2 (AIM2), a member of the pyrin-HIN family proteins, plays va...
-
Article
Open AccessClinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer
Colorectal carcinoma (CRC) is one of the most common malignancies with a dismal 5-year survival rate. Our recent study indicated that Rab1A expression was closely related to GLI1 expression. A previous study s...
-
Article
Open AccessExpression analysis and implication of Rab1A in gastrointestinal relevant tumor
Gastrointestinal cancers have become increasingly prevalent worldwide. Previous studies have reported an oncogenic function of Rab1A in colorectal cancer and hepatocellular carcinomas via the mTOR pathway. How...